Image Analysis of Ca2+ Signals As a Basis for Neurotoxicity Assays: Promises and Challenges
Overview
Toxicology
Affiliations
Free intracellular calcium ([Ca(2+)](i)) controls a wide range of cellular functions such as contraction, neurotransmitter and hormone release, metabolism, cell division and differentiation. Cytosolic Ca(2+) levels are abnormal in cells exposed to toxicants and understanding how these levels become altered may improve our ability to design high-throughput methods for the sensitive detection of cellular responses to a toxic exposure. Because Ca(2+) is involved in multiple aspects of cellular function, its role in signaling is complex. It is therefore necessary to identify the individual pathways targeted during toxicant exposure in order to use them as a tool for predictive measurements of toxicity and as targets for prevention or reversal of injury. This review illustrates several methods available for analysis of Ca(2+) responses in vitro and their applicability for understanding mechanisms of toxicity at the molecular and cellular levels. The review will also consider the usefulness of Ca(2+) imaging for predicting a unique signature for classes of toxicants. Towards this end, two methodological approaches for assessment of Ca(2+) responses to toxicants are examined: steady state measurements and complex spatial and/or temporal measurements. Each of the methods described and appropriately used results in reliable and reproducible measurements which may be applied in a high-throughput fashion to individualize in vitro assessment of cellular responses caused by toxicants.
Thallium's Threat to Aquatic Life: Stage-Specific Toxicity in Zebrafish Embryos and Larvae.
Liu J, Yan G, Huo Z, Mo Y, Wen Y, Liu W Environ Health (Wash). 2024; 2(3):114-125.
PMID: 39473815 PMC: 11504704. DOI: 10.1021/envhealth.3c00196.
Effect of preconditioning on propofol-induced neurotoxicity during the developmental period.
Shibuta S, Morita T, Kosaka J PLoS One. 2022; 17(8):e0273219.
PMID: 35984772 PMC: 9390907. DOI: 10.1371/journal.pone.0273219.
Hagedorn P, Brown J, Easton A, Pierdomenico M, Jones K, Olson R Nucleic Acid Ther. 2022; 32(3):151-162.
PMID: 35166597 PMC: 9221153. DOI: 10.1089/nat.2021.0071.
Temido-Ferreira M, Ferreira D, Batalha V, Marques-Morgado I, Coelho J, Pereira P Mol Psychiatry. 2018; 25(8):1876-1900.
PMID: 29950682 PMC: 7387321. DOI: 10.1038/s41380-018-0110-9.
Sachana M, Rolaki A, Bal-Price A Toxicol Appl Pharmacol. 2018; 354:153-175.
PMID: 29524501 PMC: 6095943. DOI: 10.1016/j.taap.2018.02.024.